Y-Intercept (HK)’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,354
Closed -$773K – 1931
2026
Q2
$773K Buy
+10,354
New +$745K 0.02% 1149
2026
Q1
– Sell
-7,474
Closed -$442K – 1897
2025
Q4
$442K Sell
7,474
-5,340
-42% -$290K 0.01% 1266
2025
Q3
$707K Buy
+12,814
New +$666K 0.02% 1127
2024
Q3
– Sell
-7,758
Closed -$339K – 1632
2024
Q2
$339K Sell
7,758
-2,015
-21% -$97.4K 0.02% 983
2024
Q1
$466K Buy
+9,773
New +$439K 0.04% 745
2023
Q4
– Sell
-19,513
Closed -$929K – 1508
2023
Q3
$929K Buy
+19,513
New +$1.07M 0.09% 339
2023
Q2
– Sell
-10,004
Closed -$715K – 1568
2023
Q1
$715K Buy
+10,004
New +$794K 0.08% 372

Other funds holding NGVT

Y-Intercept (HK)'s NGVT Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Ingevity (NGVT) in Q3 2026, closing a stake of 10,354 shares — an estimated $773K sold.

Y-Intercept (HK) first reported a position in NGVT in Q1 2023 and held it in 7 quarters. The position peaked at $929K in Q3 2023. 122 funds tracked by Wall St. Rank hold NGVT as of Q3 2026.

  • Y-Intercept (HK) reported no remaining Ingevity position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 10,354 Ingevity shares in Q3 2026, an estimated $773K.
  • Y-Intercept (HK) first reported a position in Ingevity in Q1 2023 and held it in 7 quarters.
  • Y-Intercept (HK)'s Ingevity position peaked at $929K in Q3 2023.
  • 122 funds tracked by Wall St. Rank held Ingevity as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.